Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Lesinurad Tablets From Two Manufacturing Sites
NCT02127775Phase 1Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Apr 2014
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lesinurad in gout and hyperuricemia (2 arms), sponsored by Ardea Biosciences, Inc. Primary endpoint: PK profile of lesinurad from plasma at Day 5. Started Apr 2014; status: completed.
02
Drugs
lesinurad
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on NCT02127775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02127775.